News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,630 Results
Type
Article (14962)
Company Profile (108)
Press Release (267552)
Multimedia
Podcasts (66)
Webinars (13)
Section
Business (89436)
Career Advice (475)
Deals (15581)
Drug Delivery (74)
Drug Development (39081)
Employer Resources (50)
FDA (6784)
Job Trends (6431)
News (154778)
Policy (14598)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (504)
Accelerated approval (14)
Adcomms (10)
Allergies (68)
Alliances (23651)
ALS (61)
Alzheimer's disease (499)
Antibody-drug conjugate (ADC) (110)
Approvals (6989)
Artificial intelligence (210)
Autoimmune disease (42)
Automation (12)
Bankruptcy (151)
Best Places to Work (4567)
BIOSECURE Act (9)
Biosimilars (120)
Biotechnology (42)
Bladder cancer (63)
Brain cancer (32)
Breast cancer (194)
Cancer (1552)
Cardiovascular disease (157)
Career advice (428)
Career pathing (13)
CAR-T (69)
CDC (7)
Cell therapy (189)
Cervical cancer (11)
Clinical research (34144)
Collaboration (743)
Compensation (326)
Complete response letters (33)
COVID-19 (823)
CRISPR (44)
C-suite (435)
Cystic fibrosis (60)
Data (2142)
Denatured (19)
Depression (53)
Diabetes (136)
Diagnostics (1505)
Digital health (9)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (116)
Drug pricing (116)
Drug shortages (13)
Duchenne muscular dystrophy (83)
Earnings (34167)
Editorial (20)
Employer branding (4)
Employer resources (45)
Events (40347)
Executive appointments (530)
FDA (7988)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (442)
Gene editing (71)
Generative AI (18)
Gene therapy (183)
GLP-1 (457)
Government (1505)
Grass and pollen (4)
Guidances (173)
Healthcare (3865)
HIV (14)
Huntington's disease (12)
IgA nephropathy (41)
Immunology and inflammation (74)
Immuno-oncology (15)
Indications (58)
Infectious disease (888)
Inflammatory bowel disease (76)
Inflation Reduction Act (8)
Influenza (25)
Intellectual property (117)
Interviews (61)
IPO (6021)
IRA (34)
Job creations (2063)
Job search strategy (384)
JPM (29)
Kidney cancer (10)
Labor market (29)
Layoffs (213)
Leadership (8)
Legal (3488)
Liver cancer (25)
Longevity (9)
Lung cancer (230)
Lymphoma (164)
Machine learning (13)
Management (17)
Manufacturing (421)
MASH (68)
Medical device (1483)
Medtech (1491)
Mergers & acquisitions (9987)
Metabolic disorders (457)
Multiple sclerosis (63)
NASH (14)
Neurodegenerative disease (89)
Neuropsychiatric disorders (41)
Neuroscience (968)
Neurotech (1)
NextGen: Class of 2026 (1642)
Non-profit (636)
Now hiring (17)
Obesity (242)
Opinion (147)
Ovarian cancer (44)
Pain (113)
Pancreatic cancer (58)
Parkinson's disease (84)
Partnered (11)
Patents (229)
Patient recruitment (137)
Peanut (13)
People (29912)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (9002)
Phase 2 (14413)
Phase 3 (12930)
Pipeline (2058)
Policy (140)
Postmarket research (1464)
Preclinical (3628)
Press Release (26)
Prostate cancer (93)
Psychedelics (16)
Radiopharmaceuticals (141)
Rare diseases (375)
Real estate (2676)
Recruiting (18)
Regulatory (11416)
Reports (15)
Research institute (611)
Resumes & cover letters (55)
Rett syndrome (5)
RNA editing (6)
RSV (20)
Schizophrenia (83)
Series A (82)
Series B (51)
Service/supplier (2)
Sickle cell disease (49)
Special edition (10)
Spinal muscular atrophy (84)
Sponsored (10)
Startups (1660)
State (2)
Stomach cancer (5)
Supply chain (49)
Tariffs (69)
The Weekly (45)
Vaccines (248)
Venture capital (37)
Weight loss (150)
Women's health (28)
Worklife (4)
Date
Today (28)
Last 7 days (163)
Last 30 days (728)
Last 365 days (11096)
2026 (1035)
2025 (11374)
2024 (13157)
2023 (15007)
2022 (20351)
2021 (20908)
2020 (19742)
2019 (15470)
2018 (12093)
2017 (14334)
2016 (13499)
2015 (15969)
2014 (12749)
2013 (10848)
2012 (11630)
2011 (12134)
2010 (11111)
Location
Africa (333)
Alabama (20)
Alaska (1)
Arizona (77)
Arkansas (3)
Asia (21512)
Australia (2772)
California (3426)
Canada (1528)
China (570)
Colorado (162)
Connecticut (156)
Delaware (141)
Europe (42260)
Florida (630)
Georgia (83)
Hawaii (1)
Idaho (11)
Illinois (370)
India (44)
Indiana (242)
Iowa (2)
Japan (254)
Kansas (78)
Kentucky (21)
Louisiana (4)
Maine (29)
Maryland (440)
Massachusetts (2767)
Michigan (46)
Minnesota (171)
Mississippi (1)
Missouri (34)
Montana (8)
Nebraska (7)
Nevada (17)
New Hampshire (8)
New Jersey (1468)
New Mexico (7)
New York (994)
North Carolina (630)
North Dakota (2)
Northern California (1550)
Ohio (89)
Oklahoma (5)
Oregon (19)
Pennsylvania (763)
Puerto Rico (12)
Rhode Island (17)
South America (520)
South Carolina (12)
Southern California (1513)
Tennessee (61)
Texas (477)
United States (13567)
Utah (63)
Virginia (164)
Washington D.C. (42)
Washington State (241)
West Virginia (1)
Wisconsin (38)
Wyoming (1)
282,630 Results for "prolong pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Matisse Pharmaceuticals successfully completes study with prolonged infusion of M6229 in healthy volunteers
November 14, 2025
·
3 min read
Press Releases
Prolong Pharmaceuticals to Present Phase 1/2 Data from HEMERA-1 for PP-007 in Acute Ischemic Stroke (AIS) at the 2025 World Stroke Conference (WSC)
October 20, 2025
·
3 min read
Press Releases
CytoDyn to Present Prolonged Survival Data on Leronlimab in Metastatic Triple-Negative Breast Cancer at the San Antonio Breast Cancer Symposium
November 24, 2025
·
3 min read
Insights
Biotech Investors Bet on a 2026 Rebound as Deal Activity Accelerates
After a prolonged funding chill, investors say 2026 is shaping up for continued dealmaking and diversified bets beyond oncology and immunology.
January 7, 2026
·
3 min read
·
Jennifer Smith-Parker
Press Releases
Lilly’s Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment
October 20, 2025
·
24 min read
Press Releases
FORE Biotherapeutics Presents Phase 1/2a Plixorafenib Data Demonstrating Prolonged Duration of Effect in BRAF Altered Thyroid Cancers at American Thyroid Association® 2025 Annual Meeting
September 15, 2025
·
6 min read
Press Releases
Roche’s Lunsumio and Polivy combination significantly prolongs remission for people with relapsed or refractory large B-cell lymphoma
June 23, 2025
·
11 min read
Drug pricing
CMS Finalizes Stronger Protections for Orphan Drugs Against IRA Price Negotiations
Expanded exemptions for orphan drugs could mean prolonged protections for top-selling drugs like Merck’s Keytruda, which was initially approved under this designation in 2014.
October 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Genentech’s Lunsumio and Polivy Combination Significantly Prolongs Remission for People With Relapsed or Refractory Large B-cell Lymphoma
June 23, 2025
·
19 min read
Press Releases
Prolong Pharmaceuticals to Present Preliminary Phase 1 Data from HEMERA-1 for PP-007 in Acute Ischemic Stroke (AIS) at the 2025 International Stroke Conference (ISC)
February 5, 2025
·
2 min read
1 of 28,263
Next
